Movatterモバイル変換


[0]ホーム

URL:


US20040071783A1 - Methods and apparatus for particle formation - Google Patents

Methods and apparatus for particle formation
Download PDF

Info

Publication number
US20040071783A1
US20040071783A1US10/458,792US45879203AUS2004071783A1US 20040071783 A1US20040071783 A1US 20040071783A1US 45879203 AUS45879203 AUS 45879203AUS 2004071783 A1US2004071783 A1US 2004071783A1
Authority
US
United States
Prior art keywords
solution
fluid
vehicle
supercritical fluid
supercritical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/458,792
Inventor
Mazen Hanna
Peter York
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to US10/458,792priorityCriticalpatent/US20040071783A1/en
Publication of US20040071783A1publicationCriticalpatent/US20040071783A1/en
Abandonedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

The invention provides a method for forming particles of a target substance (26), involving: (a) preparing a solution or suspension of the substance in a vehicle (21) which is or includes either a near-critical fluid (21) or a first supercritical fluid; (b) introducing the solution or suspension into a particle formation vessel (32); and (c) contacting the solution or suspension, in the particle formation vessel, with a second supercritical fluid, under conditions which allow the second supercritical fluid to cause precipitation of particles of the target substance from the solution or suspension; wherein the second supercritical fluid is miscible or substantially miscible with the vehicle and is a fluid in which the target substance is insoluble or substantially insoluble. Also provided is apparatus for use in carrying out an embodiment of the method, including a particle formation vessel and means for controlling the temperature and pressure inside it; a fluid mixing vessel and means for controlling the temperature and pressure inside it; first fluid inlet means for introducing into the fluid mixing vessel a vehicle and a solution of a target substance in a primary solvent, so as to form in the fluid mixing vessel a solution of the substance and the primary solvent in the vehicle; and second fluid inlet means for introducing the solution thus formed, preferably together with a second supercritical fluid, into the particle formation vessel. The invention also provides a particulate product formed using the method.

Description

Claims (28)

US10/458,7921998-05-152003-06-10Methods and apparatus for particle formationAbandonedUS20040071783A1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US10/458,792US20040071783A1 (en)1998-05-152003-06-10Methods and apparatus for particle formation

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
GB9810559.61998-05-15
GBGB9810559.6AGB9810559D0 (en)1998-05-151998-05-15Method and apparatus for particle formation
US09/700,441US6576262B1 (en)1998-05-151999-04-29Methods and apparatus for particle formation
US10/458,792US20040071783A1 (en)1998-05-152003-06-10Methods and apparatus for particle formation

Related Parent Applications (2)

Application NumberTitlePriority DateFiling Date
PCT/GB1999/001337ContinuationWO1999059710A1 (en)1998-05-151999-04-29Methods and apparatus for particle formation
US09/700,441ContinuationUS6576262B1 (en)1998-05-151999-04-29Methods and apparatus for particle formation

Publications (1)

Publication NumberPublication Date
US20040071783A1true US20040071783A1 (en)2004-04-15

Family

ID=10832197

Family Applications (2)

Application NumberTitlePriority DateFiling Date
US09/700,441Expired - LifetimeUS6576262B1 (en)1998-05-151999-04-29Methods and apparatus for particle formation
US10/458,792AbandonedUS20040071783A1 (en)1998-05-152003-06-10Methods and apparatus for particle formation

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
US09/700,441Expired - LifetimeUS6576262B1 (en)1998-05-151999-04-29Methods and apparatus for particle formation

Country Status (12)

CountryLink
US (2)US6576262B1 (en)
EP (1)EP1077760B1 (en)
JP (1)JP2002515324A (en)
AT (1)ATE232754T1 (en)
AU (1)AU751106B2 (en)
CA (1)CA2329902C (en)
DE (1)DE69905460T2 (en)
DK (1)DK1077760T3 (en)
ES (1)ES2193700T3 (en)
GB (1)GB9810559D0 (en)
MX (1)MXPA00011185A (en)
WO (1)WO1999059710A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20030047824A1 (en)*1997-02-212003-03-13Bradford Particle Design PlcMethod and apparatus for the formation of particles
US20030223939A1 (en)*2002-04-172003-12-04Andreas KordikowskiParticulate materials
US20030232020A1 (en)*2002-04-242003-12-18Peter YorkParticulate materials
US20040202681A1 (en)*2002-12-192004-10-14Baxter International, Inc.Process for preparing pharmaceutical formulations using supercritical fluids
US20050170000A1 (en)*2003-05-082005-08-04Walker Stephen E.Particulate materials
US20060280823A1 (en)*2001-07-202006-12-14Srinivas PalakodatyParticle formation
US20070253913A1 (en)*2003-09-102007-11-01Nahed MohsenAerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
US20080287451A1 (en)*2007-02-112008-11-20Cook Robert OMethod of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20110171141A1 (en)*2009-06-262011-07-14Kellerman Donald JAdministration of dihydroergotamine mesylate particles using a metered dose inhaler
US8080236B2 (en)2002-04-172011-12-20Nektar Therapeutics Uk, LtdParticulate materials
US9120031B2 (en)2000-11-092015-09-01Nektar TherapeuticsCompositions of particulate coformulation
US9700529B2 (en)2002-05-032017-07-11Nektar TherapeuticsParticulate materials
US9808030B2 (en)2011-02-112017-11-07Grain Processing CorporationSalt composition
US11766650B2 (en)2020-01-292023-09-26Nanoform Finland OyjSystem and method to produce particles of organic substances

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB9810559D0 (en)*1998-05-151998-07-15Bradford Particle Design LtdMethod and apparatus for particle formation
US6630121B1 (en)1999-06-092003-10-07The Regents Of The University Of ColoradoSupercritical fluid-assisted nebulization and bubble drying
GB9915975D0 (en)1999-07-071999-09-08Bradford Particle Design LtdMethod for the formation of particles
EP1090894A1 (en)*1999-10-062001-04-11Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Process for making fine particles of explosives
GB9927011D0 (en)1999-11-162000-01-12Advanced Phytonics LtdMethod for the production of particles
US6761909B1 (en)1999-12-212004-07-13Rxkinetix, Inc.Particulate insulin-containing products and method of manufacture
WO2001045731A1 (en)1999-12-212001-06-28Rxkinetix, Inc.Particulate drug-containing products and method of manufacture
FR2815540B1 (en)*2000-10-192005-06-10Separex Sa PROCESS FOR MANUFACTURING VERY FINE PARTICLES COMPRISING A PRINCIPLE INSERTED IN A HOST MOLECULE
AU2002221320B2 (en)*2000-12-082006-06-15The University Of SydneySynthesis of small particles
AUPR197000A0 (en)2000-12-082001-01-11Unisearch LimitedSynthesis of small particles
GB0102075D0 (en)2001-01-262001-03-14Astrazeneca AbProcess
CN100531886C (en)*2001-02-262009-08-26多姆普Pha.R.Ma公司 Apparatus and method for forming micron and submicron particles
US20070122353A1 (en)2001-05-242007-05-31Hale Ron LDrug condensation aerosols and kits
US7090830B2 (en)2001-05-242006-08-15Alexza Pharmaceuticals, Inc.Drug condensation aerosols and kits
US7458374B2 (en)2002-05-132008-12-02Alexza Pharmaceuticals, Inc.Method and apparatus for vaporizing a compound
US7585493B2 (en)2001-05-242009-09-08Alexza Pharmaceuticals, Inc.Thin-film drug delivery article and method of use
US7766013B2 (en)2001-06-052010-08-03Alexza Pharmaceuticals, Inc.Aerosol generating method and device
FR2830760B1 (en)2001-10-122004-06-04Pf Medicament PROCESS FOR THE PREPARATION OF AN INTERACTION COMPOUND OF ACTIVE SUBSTANCES WITH A POROUS SUPPORT BY SUPERCRITICAL FLUID
WO2003035673A1 (en)2001-10-222003-05-01Dompe S.P.A.Supercritical fluids processing: preparation of protein microparticles and their stabilisation
US7574930B2 (en)*2002-02-152009-08-18Implant Sciences CorporationTrace chemical sensing
US20050163725A1 (en)*2002-03-202005-07-28Blizzard Charles D.Method for administration of growth hormone via pulmonary delivery
US7008644B2 (en)*2002-03-202006-03-07Advanced Inhalation Research, Inc.Method and apparatus for producing dry particles
JP2005521695A (en)*2002-03-202005-07-21アドバンスト インハレーション リサーチ,インコーポレイテッド Method of administering growth hormone by pulmonary delivery
CA2482272C (en)*2002-04-122011-08-16Feyecon Development & Implementation B.V.Process for small particle formation
GB0229714D0 (en)*2002-12-202003-01-29Glaxo Group LtdNovel apparatus and method
FR2854079B1 (en)2003-04-252007-11-30Pf Medicament PROCESS FOR THE PREPARATION OF MOLECULAR COMPLEXES
JP2007516149A (en)2003-05-212007-06-21アレックザ ファーマシューティカルズ, インコーポレイテッド Method for controlling uniformity of substrate temperature, built-in heating unit and chemical supply unit using the same
US7767118B2 (en)2003-06-032010-08-03Ferro CorporationNanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
WO2004110585A1 (en)*2003-06-102004-12-23Taisho Pharmaceutical Co., Ltd.Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product
US7540286B2 (en)2004-06-032009-06-02Alexza Pharmaceuticals, Inc.Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006022714A1 (en)2004-08-122006-03-02Alexza Pharmaceuticals, Inc.Aerosol drug delivery device incorporating percussively activated heat packages
US20060280027A1 (en)*2005-06-102006-12-14Battelle Memorial InstituteMethod and apparatus for mixing fluids
WO2007009164A1 (en)2005-07-152007-01-25Eiffel Technologies LimitedMethod of particle formation
US20070120281A1 (en)*2005-11-082007-05-31Boris KhusidManufacture of fine particles and nano particles and coating thereof
EP2073790B1 (en)*2006-10-062018-05-16NewSouth Innovations Pty LimitedParticle formation
EP2476412B1 (en)*2006-10-112014-03-19Crititech, Inc.Apparatus for precipitation of small medicament particles into use containers
GB0702402D0 (en)2007-02-082007-03-21Thar Pharmaceuticals IncMethod of creating crystalline substances
WO2008112661A2 (en)2007-03-092008-09-18Alexza Pharmaceuticals, Inc.Heating unit for use in a drug delivery device
PL2229233T3 (en)*2007-12-072020-03-31Xspray Pharma Ab (Publ)Method for the production of particles
US20100294986A1 (en)*2009-05-192010-11-25Massachusetts Institute Of TechnologySupercritical fluid facilitated particle formation in microfluidic systems
US20100298602A1 (en)*2009-05-192010-11-25Massachusetts Institute Of TechnologySystems and methods for microfluidic crystallization
JP6328364B2 (en)*2012-03-262018-05-23株式会社リコー Particle manufacturing method, toner, developer, and image forming apparatus
GB201402556D0 (en)2014-02-132014-04-02Crystec LtdImprovements relating to inhalable particles
EP3325456B1 (en)2015-07-222025-09-03Anavex Life Sciences Corp.Crystal form of tetra-hydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, process for its preparation, and pharmaceutical compositions containing it
JP7096771B2 (en)*2016-04-292022-07-06ザ ソリュビィリティ カンパニー オーユー Methods and devices for determining the physicochemical properties of materials
JP6569744B2 (en)*2018-01-152019-09-04株式会社リコー Method for producing particles
EP3746138A4 (en)2018-02-022021-11-03Alexza Pharmaceuticals, Inc. ELECTRIC CONDENSATION AEROSOL DEVICE
JP2020006369A (en)*2019-08-072020-01-16株式会社リコーManufacturing method of particles
GB202312252D0 (en)2023-08-102023-09-27Inhalis Therapeutics SaCrystalline compositions
GB202318661D0 (en)2023-12-062024-01-17Crystec LtdTranexamic acid compositions

Citations (39)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4514574A (en)*1984-01-091985-04-30The Dow Chemical CompanyProcess for separating isomeric mixtures
US4582731A (en)*1983-09-011986-04-15Battelle Memorial InstituteSupercritical fluid molecular spray film deposition and powder formation
US4737384A (en)*1985-11-011988-04-12Allied CorporationDeposition of thin films using supercritical fluids
US4923720A (en)*1987-12-211990-05-08Union Carbide Chemicals And Plastics Company Inc.Supercritical fluids as diluents in liquid spray application of coatings
US4970093A (en)*1990-04-121990-11-13University Of Colorado FoundationChemical deposition methods using supercritical fluid solutions
US5043280A (en)*1987-12-281991-08-27Schwarz Pharma AgMethod and apparatus for the manufacture of a product having a substance embedded in a carrier
US5066522A (en)*1988-07-141991-11-19Union Carbide Chemicals And Plastics Technology CorporationSupercritical fluids as diluents in liquid spray applications of adhesives
US5106659A (en)*1989-10-041992-04-21Nordson CorporationMethod and apparatus for spraying a liquid coating containing supercritical fluid or liquified gas
US5196575A (en)*1992-02-191993-03-23Hoechst Celanese Corp.Supercritical separation of isomers of functional organic compounds at moderate conditions
US5221731A (en)*1991-05-301993-06-22Bayer AktiengesellschaftProcess for isolating polycarbonates with co2 under pressure
US5229486A (en)*1990-12-201993-07-20Bayer AktiengesellschaftProcess for isolating polymers from their solvents using liquids containing carbon dioxide
US5232707A (en)*1989-07-101993-08-03Syntex (U.S.A.) Inc.Solvent extraction process
US5301664A (en)*1992-03-061994-04-12Sievers Robert EMethods and apparatus for drug delivery using supercritical solutions
US5424076A (en)*1990-12-221995-06-13Schwarz Pharma AgMethod of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances
US5437798A (en)*1993-02-021995-08-01Sulzer Chemtech AgPurification of salt-charged waste water by wet oxidation under super-critical conditions
US5548004A (en)*1992-11-021996-08-20Ferro CorporationMethod of preparing coating materials
US5554382A (en)*1993-05-281996-09-10Aphios CorporationMethods and apparatus for making liposomes
US5560543A (en)*1994-09-191996-10-01Board Of Regents, The University Of Texas SystemHeat-resistant broad-bandwidth liquid droplet generators
US5639441A (en)*1992-03-061997-06-17Board Of Regents Of University Of ColoradoMethods for fine particle formation
US5707634A (en)*1988-10-051998-01-13Pharmacia & Upjohn CompanyFinely divided solid crystalline powders via precipitation into an anti-solvent
US5708039A (en)*1994-12-121998-01-13Morton International, Inc.Smooth thin film powder coatings
US5709886A (en)*1995-02-031998-01-20Eurand America, IncorporatedEffervescent microcapsules
US5725836A (en)*1993-11-081998-03-10Cf Technologies, Inc.Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles
US5770559A (en)*1992-10-141998-06-23The Regents Of The University Of ColoradoSolubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same
US5795594A (en)*1993-07-011998-08-18Glaxo Group LimitedSalmeterol xinafoate with controlled particle size
US5851453A (en)*1993-07-011998-12-22University Of BradfordMethod and apparatus for the formation of particles
US5874029A (en)*1996-10-091999-02-23The University Of KansasMethods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
US6063910A (en)*1991-11-142000-05-16The Trustees Of Princeton UniversityPreparation of protein microparticles by supercritical fluid precipitation
US6063138A (en)*1994-06-302000-05-16Bradford Particle Design LimitedMethod and apparatus for the formation of particles
US20020000681A1 (en)*2000-05-242002-01-03Gupta Ram B.Method of forming nanoparticles and microparticles of controllable size using supercritical fluids and ultrasound
US6414050B1 (en)*1997-05-102002-07-02University Of NottinghamBiofunctional polymers prepared in supercritical fluid
US6423344B1 (en)*1994-03-072002-07-23Inhale Therapeutic SystemsDispersible macromolecule compositions and methods for their preparation and use
US20020114844A1 (en)*2000-11-092002-08-22Hanna Mazen H.Particle formation methods and their products
US20030047824A1 (en)*1997-02-212003-03-13Bradford Particle Design PlcMethod and apparatus for the formation of particles
US6576262B1 (en)*1998-05-152003-06-10Nektar TherapeuticsMethods and apparatus for particle formation
US20030109421A1 (en)*2001-07-202003-06-12Srinivas PalakodatyParticle formation
US20040119179A1 (en)*2000-10-192004-06-24Michel PerrutMethod for making very fine particles consisting of a principle inserted in a host molecule
US6860907B1 (en)*1999-07-072005-03-01Nektar TherapeuticaMethod of particle formation
US20050170000A1 (en)*2003-05-082005-08-04Walker Stephen E.Particulate materials

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0885038B1 (en)1996-03-012011-06-15The University Of KansasMethods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents

Patent Citations (40)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4582731A (en)*1983-09-011986-04-15Battelle Memorial InstituteSupercritical fluid molecular spray film deposition and powder formation
US4514574A (en)*1984-01-091985-04-30The Dow Chemical CompanyProcess for separating isomeric mixtures
US4737384A (en)*1985-11-011988-04-12Allied CorporationDeposition of thin films using supercritical fluids
US4923720A (en)*1987-12-211990-05-08Union Carbide Chemicals And Plastics Company Inc.Supercritical fluids as diluents in liquid spray application of coatings
US5043280A (en)*1987-12-281991-08-27Schwarz Pharma AgMethod and apparatus for the manufacture of a product having a substance embedded in a carrier
US5066522A (en)*1988-07-141991-11-19Union Carbide Chemicals And Plastics Technology CorporationSupercritical fluids as diluents in liquid spray applications of adhesives
US5707634A (en)*1988-10-051998-01-13Pharmacia & Upjohn CompanyFinely divided solid crystalline powders via precipitation into an anti-solvent
US5232707A (en)*1989-07-101993-08-03Syntex (U.S.A.) Inc.Solvent extraction process
US5106659A (en)*1989-10-041992-04-21Nordson CorporationMethod and apparatus for spraying a liquid coating containing supercritical fluid or liquified gas
US4970093A (en)*1990-04-121990-11-13University Of Colorado FoundationChemical deposition methods using supercritical fluid solutions
US5229486A (en)*1990-12-201993-07-20Bayer AktiengesellschaftProcess for isolating polymers from their solvents using liquids containing carbon dioxide
US5424076A (en)*1990-12-221995-06-13Schwarz Pharma AgMethod of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances
US5221731A (en)*1991-05-301993-06-22Bayer AktiengesellschaftProcess for isolating polycarbonates with co2 under pressure
US6063910A (en)*1991-11-142000-05-16The Trustees Of Princeton UniversityPreparation of protein microparticles by supercritical fluid precipitation
US5196575A (en)*1992-02-191993-03-23Hoechst Celanese Corp.Supercritical separation of isomers of functional organic compounds at moderate conditions
US5301664A (en)*1992-03-061994-04-12Sievers Robert EMethods and apparatus for drug delivery using supercritical solutions
US5639441A (en)*1992-03-061997-06-17Board Of Regents Of University Of ColoradoMethods for fine particle formation
US5770559A (en)*1992-10-141998-06-23The Regents Of The University Of ColoradoSolubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same
US5548004A (en)*1992-11-021996-08-20Ferro CorporationMethod of preparing coating materials
US5437798A (en)*1993-02-021995-08-01Sulzer Chemtech AgPurification of salt-charged waste water by wet oxidation under super-critical conditions
US5554382A (en)*1993-05-281996-09-10Aphios CorporationMethods and apparatus for making liposomes
US5795594A (en)*1993-07-011998-08-18Glaxo Group LimitedSalmeterol xinafoate with controlled particle size
US5851453A (en)*1993-07-011998-12-22University Of BradfordMethod and apparatus for the formation of particles
US5725836A (en)*1993-11-081998-03-10Cf Technologies, Inc.Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles
US6423344B1 (en)*1994-03-072002-07-23Inhale Therapeutic SystemsDispersible macromolecule compositions and methods for their preparation and use
US6063138A (en)*1994-06-302000-05-16Bradford Particle Design LimitedMethod and apparatus for the formation of particles
US5560543A (en)*1994-09-191996-10-01Board Of Regents, The University Of Texas SystemHeat-resistant broad-bandwidth liquid droplet generators
US5708039A (en)*1994-12-121998-01-13Morton International, Inc.Smooth thin film powder coatings
US5709886A (en)*1995-02-031998-01-20Eurand America, IncorporatedEffervescent microcapsules
US5874029A (en)*1996-10-091999-02-23The University Of KansasMethods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
US20030047824A1 (en)*1997-02-212003-03-13Bradford Particle Design PlcMethod and apparatus for the formation of particles
US6414050B1 (en)*1997-05-102002-07-02University Of NottinghamBiofunctional polymers prepared in supercritical fluid
US6576262B1 (en)*1998-05-152003-06-10Nektar TherapeuticsMethods and apparatus for particle formation
US6860907B1 (en)*1999-07-072005-03-01Nektar TherapeuticaMethod of particle formation
US20050206023A1 (en)*1999-07-072005-09-22Hanna Mazen HMethod of particle formation
US20020000681A1 (en)*2000-05-242002-01-03Gupta Ram B.Method of forming nanoparticles and microparticles of controllable size using supercritical fluids and ultrasound
US20040119179A1 (en)*2000-10-192004-06-24Michel PerrutMethod for making very fine particles consisting of a principle inserted in a host molecule
US20020114844A1 (en)*2000-11-092002-08-22Hanna Mazen H.Particle formation methods and their products
US20030109421A1 (en)*2001-07-202003-06-12Srinivas PalakodatyParticle formation
US20050170000A1 (en)*2003-05-082005-08-04Walker Stephen E.Particulate materials

Cited By (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20030047824A1 (en)*1997-02-212003-03-13Bradford Particle Design PlcMethod and apparatus for the formation of particles
US9120031B2 (en)2000-11-092015-09-01Nektar TherapeuticsCompositions of particulate coformulation
US10798955B2 (en)2000-11-092020-10-13Nektar TherapeuticsCompositions of particulate coformulation
US20060280823A1 (en)*2001-07-202006-12-14Srinivas PalakodatyParticle formation
US20060279011A1 (en)*2001-07-202006-12-14Srinivas PalakodatyParticle formation
US10251881B2 (en)2002-04-172019-04-09Nektar TherapeuticsParticulate materials
US20030223939A1 (en)*2002-04-172003-12-04Andreas KordikowskiParticulate materials
US9616060B2 (en)2002-04-172017-04-11Nektar TherapeuticsParticulate materials
US8080236B2 (en)2002-04-172011-12-20Nektar Therapeutics Uk, LtdParticulate materials
US7582284B2 (en)2002-04-172009-09-01Nektar TherapeuticsParticulate materials
US8828359B2 (en)2002-04-172014-09-09Nektar TherapeuticsParticulate materials
US8470301B2 (en)2002-04-172013-06-25Nektar TherapeuticsParticulate materials
US20030232020A1 (en)*2002-04-242003-12-18Peter YorkParticulate materials
US8273330B2 (en)2002-04-252012-09-25Nektar TherapeuticsParticulate materials
US9700529B2 (en)2002-05-032017-07-11Nektar TherapeuticsParticulate materials
US10945972B2 (en)2002-05-032021-03-16Nektar TherapeuticsParticulate materials
US10188614B2 (en)2002-05-032019-01-29Nektar TherapeuticsParticulate materials
US20040202681A1 (en)*2002-12-192004-10-14Baxter International, Inc.Process for preparing pharmaceutical formulations using supercritical fluids
US7354601B2 (en)2003-05-082008-04-08Walker Stephen EParticulate materials
US20050170000A1 (en)*2003-05-082005-08-04Walker Stephen E.Particulate materials
US20070253913A1 (en)*2003-09-102007-11-01Nahed MohsenAerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
US20100284940A1 (en)*2007-02-112010-11-11Map Pharmaceuticals, Inc.Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20080287451A1 (en)*2007-02-112008-11-20Cook Robert OMethod of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20100081663A1 (en)*2007-02-112010-04-01Map Pharmaceuticals, Inc.Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20100081664A1 (en)*2007-02-112010-04-01Map Pharmaceuticals, Inc.Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US9833451B2 (en)2007-02-112017-12-05Map Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US10172853B2 (en)2007-02-112019-01-08Map Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US7994197B2 (en)2007-02-112011-08-09Map Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8148377B2 (en)2007-02-112012-04-03Map Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8119639B2 (en)2007-02-112012-02-21Map Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20110171141A1 (en)*2009-06-262011-07-14Kellerman Donald JAdministration of dihydroergotamine mesylate particles using a metered dose inhaler
US9808030B2 (en)2011-02-112017-11-07Grain Processing CorporationSalt composition
US11766650B2 (en)2020-01-292023-09-26Nanoform Finland OyjSystem and method to produce particles of organic substances

Also Published As

Publication numberPublication date
CA2329902A1 (en)1999-11-25
ATE232754T1 (en)2003-03-15
GB9810559D0 (en)1998-07-15
US6576262B1 (en)2003-06-10
AU3720999A (en)1999-12-06
DK1077760T3 (en)2003-06-16
AU751106B2 (en)2002-08-08
WO1999059710A1 (en)1999-11-25
DE69905460T2 (en)2004-02-26
ES2193700T3 (en)2003-11-01
EP1077760B1 (en)2003-02-19
DE69905460D1 (en)2003-03-27
EP1077760A1 (en)2001-02-28
JP2002515324A (en)2002-05-28
MXPA00011185A (en)2003-05-19
CA2329902C (en)2008-07-15

Similar Documents

PublicationPublication DateTitle
US6576262B1 (en)Methods and apparatus for particle formation
US7150766B2 (en)Method of particle formation
US5851453A (en)Method and apparatus for the formation of particles
US5795594A (en)Salmeterol xinafoate with controlled particle size
US20020010982A1 (en)Method and apparatus for the formation of particles
US7087197B2 (en)Particle formation
US7208106B2 (en)Method of forming particles
EP1409123A1 (en)Method and apparatus for preparing particles
AU2002314390A1 (en)Method and apparatus for preparing particles
US20050085409A1 (en)Particle formation
US7767118B2 (en)Nanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
GB2339165A (en)Method and apparatus for particle formation using supercritical fluids
Bolten et al.NOVEL MATERIALS FOR CONTROLLED RELEASE (CPD)

Legal Events

DateCodeTitleDescription
STCBInformation on status: application discontinuation

Free format text:ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION


[8]ページ先頭

©2009-2025 Movatter.jp